Pulse Oximetry in Healthy SubjEcts ImmergeD in OceaN. (POSEIDON)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04250532|
Recruitment Status : Recruiting
First Posted : January 31, 2020
Last Update Posted : June 23, 2020
|Condition or disease||Intervention/treatment|
The research focuses on the measurement of pulse oximetry among lifeguard on the Atlantic coast of Gironde, France, before and after their daily training, using a standardized measurement protocol.
The follow-up will be done during the beach monitoring period during the summer of 2020. A total of 3 months of measurement collection is expected.
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||Pulse Oximetry in Healthy SubjEcts ImmergeD in OceaN.|
|Estimated Study Start Date :||June 30, 2020|
|Estimated Primary Completion Date :||September 30, 2020|
|Estimated Study Completion Date :||September 30, 2020|
Lifeguards who work on the Atlantic coast of Gironde France.
Measurement of pulse oximetry, after lifeguard immersion during their morning training
- Proportion of abnormal pulse oximetry measure [ Time Frame: 3 months after inclusion day ]Quantify the number of subjects, whose pulse oximetry is measured as abnormal (superior to 94%) after immersion for 15 min in the ocean, in real condition.
- Variation of pulse oximetry according to individuals factors [ Time Frame: 3 months after inclusion day ]Measures of immersion time, BMI before / after immersion.
- Variation of pulse oximetry according to environnementals factors [ Time Frame: 3 months after inclusion day ]Measures of air, water temperatures, felt air temperature, wet thermometer temperature, wind speed before / after immersion.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04250532
|Contact: Eric TELLIER, Dr||5 56 79 56 79 ext +email@example.com|
|Contact: Samuel MOREAU||5 56 79 56 79 ext +firstname.lastname@example.org|
|Bordeaux, France, 33000|
|Contact: Eric TELLIER, Dr 0556795679 email@example.com|
|Principal Investigator: Eric TELLIER, Dr|
|Sub-Investigator: Bruno SIMONNET, Dr|